1. Home
  2. VIV vs BNTX Comparison

VIV vs BNTX Comparison

Compare VIV & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telefonica Brasil S.A.

VIV

Telefonica Brasil S.A.

HOLD

Current Price

$15.69

Market Cap

25.6B

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$101.61

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIV
BNTX
Founded
1973
2008
Country
Brazil
Germany
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.6B
24.2B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
VIV
BNTX
Price
$15.69
$101.61
Analyst Decision
Hold
Strong Buy
Analyst Count
4
13
Target Price
$14.80
$133.46
AVG Volume (30 Days)
876.0K
801.0K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.22
N/A
Revenue Next Year
$5.52
$3.37
P/E Ratio
$22.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.51
$79.81
52 Week High
$17.26
$124.00

Technical Indicators

Market Signals
Indicator
VIV
BNTX
Relative Strength Index (RSI) 43.12 54.77
Support Level $15.17 $99.08
Resistance Level $16.47 $113.02
Average True Range (ATR) 0.33 3.69
MACD -0.11 0.62
Stochastic Oscillator 14.85 51.23

Price Performance

Historical Comparison
VIV
BNTX

About VIV Telefonica Brasil S.A.

Telefonica Brasil, known as Vivo, is the largest wireless carrier in Brazil with 102 million customers, which is equal to about 39% market share. The firm is strongest in the postpaid business, where it has 68 million customers, or about 41% share of this market. Wireless services and equipment contribute about 70% of total revenue. Vivo is the incumbent fixed-line telephone operator in Sao Paulo state and also owns an extensive fiber network across the country. The firm provides internet access to 8 million households on this network. The firm also sells pay-TV and phone services to its fixed-line customers. Finally, corporate data and IT services, including cloud computing support, contribute about 9% of total revenue.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: